Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-26
2011-04-26
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S252110, C514S253010, C514S254080, C540S575000, C544S121000, C544S230000, C544S357000, C544S360000, C544S364000, C544S373000, C544S400000
Reexamination Certificate
active
07932247
ABSTRACT:
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
REFERENCES:
patent: 5510478 (1996-04-01), Sabb
patent: 7232841 (2007-06-01), Busch-Petersen et al.
patent: 7276521 (2007-10-01), Busch-Petersen et al.
patent: 7439255 (2008-10-01), Wan et al.
patent: 7488827 (2009-02-01), Laine et al.
patent: 7495010 (2009-02-01), Belmonte et al.
patent: 7498440 (2009-03-01), Laine et al.
patent: 7507753 (2009-03-01), Cho et al.
patent: 7563803 (2009-07-01), Wan et al.
patent: 7576096 (2009-08-01), Busch-Petersen et al.
patent: 7579345 (2009-08-01), Busch-Petersen et al.
patent: 7579361 (2009-08-01), Busch-Petersen et al.
patent: 7598267 (2009-10-01), Laine et al.
patent: 2005/0277676 (2005-12-01), Laine et al.
patent: 2006/0160844 (2006-07-01), Belmonte et al.
patent: 2006/0178395 (2006-08-01), Belmonte et al.
patent: 2007/0135478 (2007-06-01), Palovich et al.
patent: 2007/0149598 (2007-06-01), Busch-Petersen et al.
patent: 2007/0179180 (2007-08-01), Busch-Petersen et al.
patent: 2007/0179184 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185088 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185090 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185148 (2007-08-01), Busch-Petersen et al.
patent: 2007/0293531 (2007-12-01), Busch-Petersen et al.
patent: 2008/0249127 (2008-10-01), Laine et al.
patent: 2008/0287487 (2008-11-01), Cooper et al.
patent: 2009/0076061 (2009-03-01), Busch-Petersen et al.
patent: 2009/0124653 (2009-05-01), Laine et al.
patent: 2009/0142279 (2009-06-01), Budzik et al.
patent: 2009/0149447 (2009-06-01), Budzik et al.
patent: 2009/0253908 (2009-10-01), Budzik et al.
patent: 2009/0258858 (2009-10-01), Busch-Petersen et al.
patent: 2009/0275604 (2009-11-01), Wan et al.
patent: 1 295 867 (2003-03-01), None
patent: 1 331 010 (2003-07-01), None
patent: 02/44137 (2002-06-01), None
patent: 03/033483 (2003-04-01), None
patent: WO2005/087236 (2005-09-01), None
patent: 2006/062883 (2006-06-01), None
patent: 2006/062931 (2006-06-01), None
patent: 2006/065755 (2006-06-01), None
patent: 2006/065788 (2006-06-01), None
patent: 2007/018508 (2007-02-01), None
patent: 2007/018514 (2007-02-01), None
Pauwels et al., Am J Respir Crit Care Med, vol. 163, p. 1256-1276 (2001).
Caufield, Pharmac. Ther., vol. 58, p. 319-379 (1993).
Fryer and Jacoby, Am J. Respir Crit Care Med., p. 154-160 (1998).
Seifart et al., Expert Opinion, Emerging Drugs, (14) 1, pp. 181-194 (2009).
Gross, N, European Journal of Pharmacology, 533 (2006), pp. 36-39.
Cazzola et al., European Respiratory Journal, (34), p. 1-13 (2009).
Most Recent Office Action U.S. Appl. No. 10/598,743, Oct. 6, 2010.
Budzik Brian W.
Cooper Anthony W. J.
Jin Jian
Laine Dramane I.
McCleland Brent W.
Bernhardt Emily
Dinner Dara L.
Furman Theodore
Glaxo Group Limited
LandOfFree
M 3 muscarinic acetylcholine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with M 3 muscarinic acetylcholine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M 3 muscarinic acetylcholine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656007